2018
DOI: 10.1371/journal.pntd.0006393
|View full text |Cite|
|
Sign up to set email alerts
|

A novel immunotherapy of Brucellosis in cows monitored non invasively through a specific biomarker

Abstract: Brucellosis is an important zoonotic disease causing huge economic losses worldwide. Currently no effective immunotherapy for Brucellosis or any biomarker to monitor the efficacy of therapy is available. Treatment is ineffective and animals remain carrier lifelong. S19 and RB51 are live attenuated vaccine strains of Brucella abortus. However, S19 induces only antibody, ineffective for intracellular pathogen. RB51 induces cell mediated immunity (CMI) but it is Rifampicin resistant. Both organisms are secreted i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(20 citation statements)
references
References 26 publications
0
19
0
Order By: Relevance
“…This combination of doxycycline and rifampicin has also been proven experimentally [ 112 ]. As a result of continued efforts by the scientific community to develop an effective therapeutics, Caryopteris mongolica Bunge (Lamiaceae) has been tested in combination with doxycycline [ 113 , 114 ]. Despite the fact that several therapeutics are in practice which makes the disease manageable, an effective therapeutic is required for the complete treatment of brucellosis.…”
Section: Treatment Of Brucellosismentioning
confidence: 99%
See 1 more Smart Citation
“…This combination of doxycycline and rifampicin has also been proven experimentally [ 112 ]. As a result of continued efforts by the scientific community to develop an effective therapeutics, Caryopteris mongolica Bunge (Lamiaceae) has been tested in combination with doxycycline [ 113 , 114 ]. Despite the fact that several therapeutics are in practice which makes the disease manageable, an effective therapeutic is required for the complete treatment of brucellosis.…”
Section: Treatment Of Brucellosismentioning
confidence: 99%
“…S19 and RB51 are live attenuated vaccines derived from B. abortus [ 126 ]. A cocktail lysate of S19 and RB51 was also tested as an immune-therapy to treat the bracelet infected cattle [ 114 ]. DNA vaccines have also been tested and show promising results when compared with S19 and RB51; however, several boosters were required to achieve the desired immunity [ 127 , 128 ].…”
Section: Vaccination Against Brucellosismentioning
confidence: 99%
“…Among these two phage lysates, RL projected stronger cell-mediated immune response while SL stimulated higher level of humoral immune response. Results of the study are promising to encourage the use of bacteriophage lysates in treatment of bovine brucellosis (Saxena and Raj 2018 ).…”
Section: Treatmentmentioning
confidence: 95%
“…Al-Ajlan et al, (2011) compared the DNA and RNA detection PCR methods for identifying Brucella species in human blood samples. Saxena and Raj (2018) employed RT-PCR for monitoring and assessment of efficacy of immunotherapy against Brucellosis in cattle.…”
Section: Rt-pcrmentioning
confidence: 99%